Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

NCT06653348 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Transient Ischemic Attack

Interventions

DRUG: Ticagrelor 60 + Aspirin
DRUG: Ticagrelor 90 + aspirin

Sponsor

Mazandaran University of Medical Sciences